CSIMarket


Bioxytran Inc   (BIXT)
Other Ticker:  
 

Bioxytran Inc

BIXT's Fundamental analysis








Bioxytran Inc 's sales fell in II. Quarter 2024 from the same quarter a year ago.

Major Pharmaceutical Preparations industry recorded growth of revenues by 5.15 %

Bioxytran Inc net loss decreased from $-1 millions, to $-1 millions in II. Quarter 2024,

More on BIXT's Growth


Bioxytran Inc
realized a net loss in trailing twelve months.

Bioxytran Inc realized cash reduction of $ -0 per share in trailing twelve-month period.
Company
-
PE TTM   
Industry
-
PE TTM    
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.55.


More on BIXT's Valuation
 
 Total Debt (Millions $) 0
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Revenue/Employee (TTM) $ -
 Net Income/Employee (TTM) $ -
 Receivable Turnover (TTM) -
 Tangible Book Value (Per Share $) -0.01

Bioxytran Inc
realized net loss in trailing twelve months.

Bioxytran Inc realized cash outflow of $ -0per share in trailing twelve-month period.
Company
-
PE TTM   
Industry
-
PE TTM    
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.55.


More on BIXT's Valuation

  Market Capitalization (Millions $) 16
  Shares Outstanding (Millions) 177
  Employees -
  Revenues (TTM) (Millions $) -
  Net Income (TTM) (Millions $) -4
  Cash Flow (TTM) (Millions $) 0
  Capital Exp. (TTM) (Millions $) 0
  Total Debt (Millions $) 0
  Dividend TTM ($) 0 $
  Dividend Yield TTM (%) -
  Revenue/Employee (TTM) $ -
  Net Income/Employee(TTM) $ -
  Receivable Turnover Ratio (TTM) -
  Tangible Book Value (Per Share $) -0.01

  Market Capitalization (Millions $) 16
  Shares Outstanding (Millions) 177
  Employees -
  Revenues (TTM) (Millions $) -
  Net Income (TTM) (Millions $) -4
  Cash Flow (TTM) (Millions $) 0
  Capital Exp. (TTM) (Millions $) 0





  Ratio
   Capital Ratio (MRQ) 0.01
  Total Debt to Equity (MRQ) -
  Tangible Leverage Ratio (MRQ) -
  Asset Turnover Ratio (TTM) -
  Inventory Turnover Ratio (TTM) -





Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com